Viral determinants of miR-122-independent hepatitis C virus replication

mSphere

Volumn 1, Issue 1, 2016, Pages

  Hopcraft, Sharon E ^a   Azarm, Kristopher D ^a   Israelow, Benjamin ^a   Lévêque, Nicolas ^b,c   Schwarz, Megan C ^a   Hsu, Tien Huei ^a   Chambers, Matthew T ^a   Sourisseau, Marion ^a   Semler, Bert L ^c   Evans, Matthew J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b University of Reims Champagne Ardenne   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CRISPR; Hepatitis C virus; MicroRNA; MiR 122

Indexed keywords

EID: 84977094588     PISSN: None     EISSN: 23795042     Source Type: Journal    
DOI: 10.1128/mSphere.00009-15     Document Type: Article

References (34)

1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. 2013. Global epidemiology of hepatitis C virus infection: new estimates of agespecific antibody to HCV seroprevalence. Hepatology 57:1333-1342. http://dx.doi.org/10.1002/hep.26141
2. Brown RS, Jr. 2005. Hepatitis C and liver transplantation. Nature 436: 973-978. http://dx.doi.org/10.1038/nature04083
3. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309:1577-1581. http://dx.doi.org/10.1126/science.1113329
4. Jopling CL, Schütz S, Sarnow P. 2008. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe 4:77-85. http://dx.doi.org/10.1016/ j.chom.2008.05.013
5. Norman KL, Sarnow P. 2010. Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms. J Virol 84:666-670. http://dx.doi.org/ 10.1128/JVI.01156-09
6. Henke JI, Goergen D, Zheng J, Song Y, Schüttler CG, Fehr C, Jünemann C, Niepmann M. 2008. microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 27:3300-3310. http://dx.doi.org/10.1038/ emboj.2008.244
7. Jangra RK, Yi M, Lemon SM. 2010. Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122. J Virol 84:6615-6625. http://dx.doi.org/10.1128/JVI.00417-10
8. Machlin ES, Sarnow P, Sagan SM. 2011. Masking the 5= terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex. Proc Natl Acad Sci U S A 108:3193-3198. http://dx.doi.org/10.1073/pnas.1012464108
9. Narbus CM, Israelow B, Sourisseau M, Michta ML, Hopcraft SE, Zeiner GM, Evans MJ. 2011. HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle. J Virol 85:12087-12092. http://dx.doi.org/10.1128/JVI.05843-11
10. Thibault PA, Huys A, Dhillon P, Wilson JA. 2013. MicroRNA-122-dependent and-independent replication of hepatitis C virus in Hep3B human hepatoma cells. Virology 436:179-190. http://dx.doi.org/ 10.1016/j.virol.2012.11.007
11. Shimakami T, Yamane D, Welsch C, Hensley L, Jangra RK, Lemon SM. 2012. Base pairing between hepatitis C virus RNA and microRNA 122 3= of its seed sequence is essential for genome stabilization and production of infectious virus. J Virol 86:7372-7383. http://dx.doi.org/ 10.1128/JVI.00513-12
12. Wilson JA, Zhang C, Huys A, Richardson CD. 2011. Human Ago2 is required for efficient microRNA 122 regulation of hepatitis C virus RNA accumulation and translation. J Virol 85:2342-2350. http://dx.doi.org/ 10.1128/JVI.02046-10
13. Shimakami T, Yamane D, Jangra RK, Kempf BJ, Spaniel C, Barton DJ, Lemon SM. 2012. Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc Natl Acad Sci U S A 109:941-946. http://dx.doi.org/ 10.1073/pnas.1112263109
14. Li Y, Masaki T, Yamane D, McGivern DR, Lemon SM. 2013. Competing and noncompeting activities of miR-122 and the 5= exonuclease Xrn1 in regulation of hepatitis C virus replication. Proc Natl Acad Sci U S A 110:1881-1886. http://dx.doi.org/10.1073/pnas.1213515110
15. Sedano C, Sarnow P. 2014. Hepatitis C virus subverts liver-specific miR-122 to protect the viral genome from exoribonuclease Xrn2. Cell Host Microbe 16:257-264. h t t p: / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j.chom.2014.07.006
16. Masaki T, Arend K, Li Y, Yamane D, McGivern D, Kato T, Wakita T, Moorman N, Lemon S. 2015. miR-122 stimulates hepatitis C virus RNA synthesis by altering the balance of viral RNAs engaged in replication versus translation. Cell Host Microbe 17:217-228. http://dx.doi.org/ 10.1016/j.chom.2014.12.014
17. Israelow B, Mullokandov G, Agudo J, Sourisseau M, Bashir A, Maldonado AY, Dar AC, Brown BD, Evans MJ. 2014. Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors. Nat Commun 5:5408. http://dx.doi.org/10.1038/ncomms6408
18. Blight KJ, McKeating JA, Rice CM. 2002. Highly permissive cell lines for hepatitis C virus genomic and subgenomic RNA replication. J Virol 76:13001-13014. http://dx.doi.org/10.1128/JVI.76.24.13001-13014.2002
19. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. 2013. RNA-guided human genome engineering via Cas9. Science 339:823-826. http://dx.doi.org/10.1126/science.1232033
20. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816-821. http://dx.doi.org/10.1126/ science.1225829
21. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339:819-823. http://dx.doi.org/ 10.1126/science.1231143
22. Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S, Steinmann E, Abid K, Negro F, Dreux M, Cosset F-, Bartenschlager R. 2006. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci U S A 103:7408-7413. http://dx.doi.org/10.1073/pnas.0504877103
23. Vieyres G, Pietschmann T. 2013. Entry and replication of recombinant hepatitis C viruses in cell culture. Methods 59:233-248. http:// dx.doi.org/10.1016/j.ymeth.2012.09.005
24. Carroll SS, Tomassini JE, Bosserman M, Getty K, Stahlhut MW, Eldrup AB, Bhat B, Hall D, Simcoe AL, LaFemina R, Rutkowski CA, Wolanski B, Yang Z, Migliaccio G, De Francesco R, Kuo LC, MacCoss M, Olsen DB. 2003. Inhibition of hepatitis C virus RNA replication by 2=-modified nucleoside analogs. J Biol Chem 278:11979-11984. http:// dx.doi.org/10.1074/jbc.M210914200
25. Fukushi S, Okada M, Kageyama T, Hoshino FB, Nagai K, Katayama K. 2001. Interaction of poly(rC)-binding protein 2 with the 5=-terminal stem loop of the hepatitis C-virus genome. Virus Res 73:67-79. http:// dx.doi.org/10.1016/S0168-1702(00)00228-8
26. Fontanes V, Raychaudhuri S, Dasgupta A. 2009. A cell-permeable peptide inhibits hepatitis C virus replication by sequestering IRES transacting factors. Virology 394:82-90. http://dx.doi.org/10.1016/ j.virol.2009.08.012
27. Wang L, Jeng K, Lai MMC. 2011. Poly(C)-binding protein 2 interacts with sequences required for viral replication in the hepatitis C virus (HCV) 5= untranslated region and directs HCV RNA replication through circularizing the viral genome. J Virol 85:7954-7964. http://dx.doi.org/ 10.1128/JVI.00339-11
28. Li Y, Masaki T, Shimakami T, Lemon SM. 2014. hnRNP L and NF90 interact with hepatitis C virus 5=-terminal untranslated RNA and promote efficient replication. J Virol 88:7199-7209. http://dx.doi.org/10.1128/ JVI.00225-14
29. Hopcraft SE, Evans MJ. 2015. Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudins. Hepatology 62:1059-1069. http:// dx.doi.org/10.1002/hep.27815
30. Mullokandov G, Baccarini A, Ruzo A, Jayaprakash AD, Tung N, Israelow B, Evans MJ, Sachidanandam R, Brown BD. 2012. Highthroughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nat Methods 9:840-846. http:// dx.doi.org/10.1038/nmeth.2078
31. Michta ML, Hopcraft SE, Narbus CM, Kratovac Z, Israelow B, Sourisseau M, Evans MJ. 2010. Species-specific regions of occludin required by hepatitis C virus for cell entry. J Virol 84:11696-11708. http:// dx.doi.org/10.1128/JVI.01555-10
32. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-626. http://dx.doi.org/10.1126/science.1114016
33. Sourisseau M, Michta ML, Zony C, Israelow B, Hopcraft SE, Narbus CM, Parra Martin A, Evans MJ. 2013. Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies. PLoS Pathog 9:e1003244. http://dx.doi.org/10.1371/journal.ppat.1003244
34. Blight KJ, Kolykhalov AA, Rice CM. 2000. Efficient initiation of HCV RNA replication in cell culture. Science 290:1972-1974. http:// dx.doi.org/10.1126/science.290.5498.1972